Truist Securities Reiterates Buy Rating on Procept BioRobotics Corp (PRCT)
Tweet Send to a Friend
Truist Securities analyst Richard Newitter reiterated a Buy rating and $74.00 price target on Procept BioRobotics Corp (NASDAQ: PRCT).The analyst ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
